Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

BETASERC 24 TABLET 24 MG [SIN12235P]

Active ingredients: BETAHISTINE 2HCL

View product's general information
Last updated 16 September 2026

Product Info

BETASERC 24 TABLET 24 MG

[SIN12235P]

Product information

Active Ingredient and Strength

BETAHISTINE 2HCL - 24 MG

Dosage Form

TABLET

Manufacturer and Country

MYLAN LABORATORIES SAS - FRANCE

Registration Number

SIN12235P

Licence Holder

ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

N07CA01

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

Therapeutic Indications
Ménière’s Syndrome as defined by the following core symptoms:

  • Vertigo (with nausea/vomiting)

  • Hearing loss (hardness of hearing)

  • Tinnitus (ringing in the ears)

Symptomatic treatment of vestibular vertigo.

Dosing

Posology and method of administration
The dosage for adults is 24–48 mg divided over the day.

Betaserc Dosage Table 1



Should be swallowed with water.

The dosage should be individually adapted according to the response. Improvement can sometimes only be observed after a couple of weeks of treatment. The best results are sometimes obtained only after a few months.

There are indications that treatment from the onset of the disease prevents its progression and/or the loss of hearing in later phases of the disease.

Pediatric population:
Betaserc is not recommended for use in children under the age of 18 years due to insufficient data on safety and efficacy.

Contraindications

Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Phaeochromocytoma.